Slingshot members are tracking this event:
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jul 25, 2016
- Evaluating the Phase 2 data on PEGPH20 in Advanced Pancreatic Cancer HALO Executed On: Mar 09, 2017 at 01:00 PM EST
Related Keywords Pegph20, Keytruda, Pembrolizumab, Gastric Cancers, Nsclc